| |
 |

 
Adjunct
Assistant Professor of Research,
Department of Pathology, University of Virginia
University
Email Address: oghribi@medicine.nodak.edu
Office Phone: 701-777-2522
Office Fax: 701-777-4490
|
Keywords:
Alzheimer’s disease, Parkinson’s disease,
Neurodegeneration, Aging, Apoptosis, Oxidative stress,
Endoplasmic reticulum, Calcium, Protein misfolding, Mitochondria,
ß-amyloid, Amyloid plaques, Tau, Neurofibrillary
tangles, Cholesterol, Copper, Iron, GSK-3, MAP Kinases,
Cdk-5
Education/Training:
- Research Associate then Assistant Professor of Research,
Department of Pathology, University of Virginia
- Postdoctoral Fellow, Laval University and University
of Quebec, Canada.
- Ph.D., Experimental and Clinical Pharmacology, School
of Pharmacy, University Rene Descartes, Paris, France.
Research Interests:
Alzheimer's disease is a devastating neurodegenerative
disorder with no known etiology or available cure. This
disease is characterized histopathologically by plaques,
tangles, and neuronal loss in selected regions of the
brain. Plaques consist of aggregates of ß-amyloid
(Aß) peptide and tangles are composed of hyperphosphorylated
forms of the microtubule-associated protein tau. The role
of Aß and tau in the pathogenesis of Alzheimer’s
disease, and the mechanisms by which neurons die in the
course of this disease, are still a matter of debate.
The broad long-term objectives of my research are to
elucidate temporal and spatial relationships between Aß,
phosphorylated tau and neuronal death, as well as intracellular
mechanisms that control these pathological features. An
integral part of my research interests is also to apply
strategies for neuroprotection as an initial step in devising
therapeutic approaches for the treatment of Alzheimer’s
disease.
My research focuses on:
(A) Role of diet and environmental factors
in the pathogenesis of Alzheimer’s disease:
The majority of Alzheimer’s disease cases are
sporadic, without a clear or defined genetic link, suggesting
that factors such as the environment or diet may contribute
to the etiology of the disease. Emerging data from epidemiological,
cell biology and animal studies supports a tight association
between dysregulation in cholesterol homeostasis and
the pathogenesis of Alzheimer’s disease. However,
the extent to which and the mechanisms by which cholesterol
may influence the induction or progression of Alzheimer’s
disease remain to be determined. Pharmacological manipulation
of cholesterol levels and/or effects may offer potential
therapeutic benefits if a connection between cholesterol
and the pathophysiology of AD can be identified. My
research aims to determine functional links between
cholesterol imbalance and triggering of Alzheimer’s
disease-like pathological features in animal models.
(B) Role of calcium and the endoplasmic reticulum
(ER) in underlying neurodegeneration in Alzheimer’s
disease: Calcium is essential to neuronal functions,
and neuronal survival depends on maintenance of calcium
homeostasis. Most of the cellular calcium is stored
in the ER, which is also a site where Aß is formed.
Impairment of calcium signaling has been suggested to
be an early event that precedes the manifestation of
Alzheimer’s disease and initiates the accumulation
of Aß peptide, which in turn triggers the phosphorylation
of tau and cell death. Our working hypothesis is that
Aß per se dysregulates calcium homeostasis in
the endoplasmic reticulum as an initial step for triggering
phosphorylation of tau and causing cell death.
Selected Publications:
- Ghribi
O. The role of the endoplasmic reticulum in the
accumulation of beta-amyloid peptide in Alzheimer's disease.
Curr Mol Med. 2006 Feb;6(1):119-33.
- Ghribi
O,
Herman MM, Pramoonjago P, Spaulding NK, Savory J. GDNF
regulates the A beta-induced endoplasmic reticulum stress
response in rabbit hippocampus by inhibiting the activation
of gadd 153 and the JNK and ERK kinases. Neurobiol
Dis. 2004;16(2):417-27.
- Ghribi
O,
Herman MM, Pramoonjago P, Savory J. MPP+ induces the endoplasmic
reticulum stress response in rabbit brain involving activation
of the ATF-6 and NF-kappaB signaling pathways. J Neuropathol
Exp Neurol. 2003;62(11):1144-53.
- Ghribi
O, Prammonjago P, Herman MM, Spaulding NK, Savory
J. Aß(1-42)-induced JNK and ERK activation in rabbit
hippocampus is differentially regulated by lithium but
is not involved in the phosphorylation of tau. Mol
Brain Res. 2003;119(2):201-6.
- Ghribi
O,
Herman MM, Savory J. Lithium inhibits Abeta-induced stress
in endoplasmic reticulum of rabbit hippocampus but does
not prevent oxidative damage and tau phosphorylation.
J Neurosci Res. 2003; 71(6):853-62.
- Savory J, Ghribi O, Herman MM. Is amyloid
beta-peptide neurotoxic or neuroprotective and what is
its role in the binding of metal ions. Neurobiol Aging.
2002;23(6):1089-92.
- Ghribi
O, Herman MM, Spaulding NK, Savory J. Lithium
inhibits aluminum-induced apoptosis in rabbit hippocampus,
by preventing cytochrome c translocation, Bcl-2 decrease,
Bax elevation and caspase-3 activation. J Neurochem.
2002;82(1):137-45.
- Ghribi
O, Herman MM, Savory J. The endoplasmic reticulum
is the main site for caspase-3 activation following aluminum-induced
neurotoxicity in rabbit hippocampus. Neurosci Lett.
2002;324(3):217-21.
- Cyr
M, Ghribi O, Thibault C, Morissette M,
Landry M, Di Paolo T. Ovarian steroids and selective estrogen
receptor modulators activity on rat brain NMDA and AMPA
receptors. Brain Res Brain Res Rev. 2001;37(1-3):153-61.
Review.
- Ghribi
O, DeWitt DA, Forbes MS, Arad A, Herman MM, Savory
J.Cyclosporin A inhibits Al-induced cytochrome c release
from mitochondria in aged rabbits. J Alzheimers Dis.
2001;3(4):387-391.
- Ghribi
O, Herman MM, DeWitt DA, Forbes MS, Savory J.
Abeta(1-42) and aluminum induce stress in the endoplasmic
reticulum in rabbit hippocampus, involving nuclear translocation
of gadd 153 and NF-kappaB. Brain Res Mol Brain Res.
2001;96(1-2):30-8.
- Ghribi
O, DeWitt DA, Forbes MS, Herman MM, Savory J.
Co-involvement of mitochondria and endoplasmic reticulum
in regulation of apoptosis: changes in cytochrome c, Bcl-2
and Bax in the hippocampus of aluminum-treated rabbits.
Brain Res. 2001;903(1-2):66-73.
- Furling
D, Ghribi O, Lahsaini A, Mirault ME,
Massicotte G. Impairment of synaptic transmission by transient
hypoxia in hippocampal slices: improved recovery in glutathione
peroxidase transgenic mice. Proc Natl Acad Sci U S
A. 2000;97(8):4351-6.
- Ghribi
O,
Lapierre L, Girard M, Ohayon M, Nalbantoglu J, Massicotte
G. Hypoxia-induced loss of synaptic transmission is exacerbated
in hippocampal slices of transgenic mice expressing C-terminal
fragments of Alzheimer amyloid precursor protein. Hippocampus.
1999;9(3):201-5.
- Ghribi
O,
Callebert J, Verrecchia C, Plotkine M, Boulu RG. Blockers
of NMDA-operated channels decrease glutamate and aspartate
extracellular accumulation in striatum during forebrain
ischaemia in rats. Fundam Clin Pharmacol. 1995;9(2):141-6.
- Ghribi
O, Callebert J, Plotkine M, Boulu RG. L-NAME
modulates glutamate accumulation induced by K(+)-depolarization
but not by forebrain ischaemia in the rat striatum. Neurosci
Lett. 1994;174(1):34-8.
|
|